Related Experiment Video
Updated: Jul 5, 2026

Differentiation of Mouse Breast Epithelial HC11 and EpH4 Cells
Published on: February 27, 2020
ErbB4/HER4: role in mammary gland development, differentiation and growth inhibition
Rebecca S Muraoka-Cook1, Shu-Mang Feng, Karen E Strunk
1UNC-Lineberger Comprehensive Cancer Center, University of North Carolina Chapel Hill, 450 West Ave CB 7295, Chapel Hill, NC 27599, USA.
Abstract:
The ErbB receptor tyrosine kinase family has often been associated with increased growth of breast epithelial cells, as well as malignant transformation and progression. In contrast, ErbB4/HER4 exhibits unique attributes from a two step proteolytic cleavage which releases an 80 kilodalton, nuclear localizing, tyrosine kinase to a signal transduction mechanism that slows growth and stimulates differentiation of breast cells. This review provides an overview of ErbB4/HER4 in growth and differentiation of the mammary epithelium, including its physiologic role in development, the contrasting growth inhibition/tumor suppression and growth acceleration of distinct ErbB4/HER4 isoforms and a description of the unique cell cycle regulated pattern of nuclear HER4 ubiquitination and destruction.
Insights
ErbB4/HER4, unlike other ErbB receptors, uniquely slows breast cell growth and promotes differentiation. Its nuclear tyrosine kinase activity and regulated destruction are key to these tumor-suppressive functions.
Area of Science:
- Cell Biology
- Molecular Oncology
- Signal Transduction
Background:
- The ErbB receptor tyrosine kinase family is implicated in breast epithelial cell growth, malignant transformation, and cancer progression.
- ErbB4/HER4 possesses distinct properties compared to other ErbB family members, particularly its role in breast cell regulation.
Purpose of the Study:
- To review the multifaceted role of ErbB4/HER4 in mammary epithelial cell growth and differentiation.
- To elucidate the unique signaling mechanisms of ErbB4/HER4, including its nuclear functions and proteolytic processing.
Main Methods:
- Review of existing literature on ErbB4/HER4 signaling pathways.
- Analysis of proteolytic cleavage mechanisms and nuclear localization of ErbB4/HER4.
- Examination of differential effects of ErbB4/HER4 isoforms on cell growth and differentiation.
Main Results:
- ErbB4/HER4 undergoes a two-step proteolytic cleavage, releasing an 80 kDa nuclear tyrosine kinase.
- This nuclear ErbB4/HER4 fragment mediates signal transduction that inhibits breast cell growth and stimulates differentiation.
- Distinct ErbB4/HER4 isoforms exhibit contrasting effects, with some promoting tumor suppression and others potentially accelerating growth.
Conclusions:
- ErbB4/HER4 plays a complex, dual role in mammary epithelium, acting as a tumor suppressor through its nuclear kinase activity.
- The cell cycle-regulated ubiquitination and degradation of nuclear HER4 are critical for its function.
- Understanding ErbB4/HER4's unique biology is crucial for developing targeted breast cancer therapies.
Related Concept Videos
Mitogens and the Cell Cycle
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Hedgehog Signaling Pathway
Negative Regulator Molecules
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

